In the tirzepatide pivotal trials specifically, hair loss was reported in 4.9-5.3% of treatment groups compared to just 0.9% on placebo, yielding a relative risk of 5.67
Semaglutide is also approved for type 2 diabetes as an injectable and oral drug
In 2026, semaglutide patents expire in 12 countries, which together account for 47% of the global obesity burden and 49% of type 2 diabetes cases, while no patent applications for the drug were identified in an additional 150 countries
Can lifestyle habits affect the effectiveness of glutathione supplements
Lets go through how tirzepatide works, why its unlikely to become an oral option soon, and whats in production in terms of oral GLP-1 medication
The scientific value of a multi peptide research formulation often lies in the ability to generate additional insights regarding biological pathways that may not be apparent when individual compounds are studied independently